Rates are tightening, prior-auth denials are rising, and primary-care-centric value-based care has hit its ceiling on total cost of care. The plans that close the specialty-care gap in the next 90 days enter 2027 with a structural cost advantage.
The next phase of value-based-care performance runs through specialty care — not because primary care failed, but because the cost drivers that remain are specialty problems.
Across Medicare Advantage, plans have squeezed most of what primary-care-centric models can reach. What's left driving avoidable admissions is concentrated in a handful of chronic conditions — heart failure, COPD, uncontrolled diabetes, and the sleep-disordered breathing that compounds them. Rate pressure doesn't shrink that disease burden. It defers the cost. This forecast lays out the three shifts defining the next 90 days, and what the evidence says works.
The forecast
Three shifts that decide 2027
CMS · Rate environment
Rate pressure is tightening, and coding-intensity recalibration compounds it.
Problem
After coding-intensity adjustments, plans with chronic-heavy populations are projecting flat-to-negative effective rate movement into the 2027 bid cycle.
Intervention
Move avoidable specialty utilization off the inpatient ledger with condition-specific virtual specialty care that operates inside the risk arrangement.
Why it matters
Plans with specialty VBC infrastructure enter 2027 with a structural cost advantage rather than a rate problem they can't grow out of.
Payer · Prior authorization
Cardiology and pulmonology PA denials are rising.
Problem
Tighter utilization management delays the specialist visit — it doesn't prevent the admission. For CHF and COPD, a 30-day specialist delay measurably raises readmission probability.
Intervention
Virtual specialty access within 24–48 hours, working alongside — not against — the plan's UM pathways, so high-risk members are seen before they decompensate.
Why it matters
Speed-to-specialist is a cost-of-care lever, not a member-experience nicety. Getting there first is what avoids the admission.
VBC · Risk groups
Primary-care-centric VBC has hit its ceiling on total cost of care.
Problem
Across risk-bearing groups, inpatient spend won't move, because the remaining cost drivers are specialty problems that primary care isn't resourced to manage.
Intervention
Layer integrated cardiology, pulmonology, endocrinology, and sleep management onto the existing VBC model, targeted to the members driving spend.
Why it matters
The next increment of savings comes from specialty care. Groups that add it now define the benchmark others chase.
The evidence
What the published literature shows
Structured remote telemonitoring has a durable, peer-reviewed effect on the exact utilization that drives MA inpatient spend.
Heart-failure hospitalizations, indexed to usual care = 100. Non-invasive telemonitoring vs. usual care. Source: Cochrane Database of Systematic Reviews 2015; CD007228 (RR 0.71). See references.
The same body of evidence links structured telemonitoring to roughly 20% lower all-cause mortality in heart failure, and telehealth remote monitoring to a mean HbA1c reduction of about 0.55% in type 2 diabetes. These are population-level effects on admissions, mortality, and control — the levers that decide total cost of care.
Identification through monitoring, run by specialists, inside the plan's risk arrangement.
🔍
Identify
Risk-stratify the members driving spend
📱
Enroll
Engage and equip with connected monitoring
🩺
Diagnose
Specialist assessment within 24–48h
❤️
Treat
Condition-specific specialty management
📈
Monitor
Escalate on deterioration, before the admission
The outcomes
Where the cost sits — and what moves it
Problem, intervention, and the measurable result, by specialty.
Published evidence
Heart failure
↓29%Hospitalizations
CHF readmissions dominate inpatient spend. Structured telemonitoring reduces heart-failure hospitalizations vs. usual care (Cochrane, RR 0.71).
Published evidence
Type 2 diabetes
↓0.55%Mean HbA1c
Uncontrolled diabetes drives downstream cost. Telehealth remote monitoring lowers mean HbA1c vs. usual care (BMC Health Serv Res, 2018).
Circadian program
COPD & sleep
Program dataObserved · methodology
COPD exacerbations are preventable and recurring; sleep-disordered breathing is MA's most underdiagnosed CHF/COPD comorbidity. Program outcomes available under case study.
Circadian program figures are observed results from defined populations and measurement periods; each is published with its methodology and comparison group in the corresponding case study.
References & authority
Sources
Published: September 2026. Last updated: September 2026.
Inglis SC, Clark RA, Dierckx R, Prieto-Merino D, Cleland JGF. Structured telephone support or non-invasive telemonitoring for patients with heart failure. Cochrane Database of Systematic Reviews 2015;(10):CD007228. (Heart-failure hospitalizations RR 0.71; all-cause mortality RR 0.80.)
Lee PA, Greenfield G, Pappas Y. The impact of telehealth remote patient monitoring on glycemic control in type 2 diabetes. BMC Health Services Research 2018;18:495. (Mean HbA1c reduction ≈0.55%.)
